- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tattoo ink masquerades as lesions
Sailors and bikers aren't the only ones getting tattoos these days. As more and more "mainstream" women get tattoos, physicians are finding the ink from the tattoos can migrate to the lymph nodes and show up on screening mammograms.
Sailors and bikers aren't the only ones getting tattoos these days. As more and more "mainstream" women get tattoos, physicians are finding the ink from the tattoos can migrate to the lymph nodes and show up on screening mammograms.
Researchers at the Beth Israel Medical Center in New York City presented a case report in the September issue of the American Journal of Roentgenology describing a patient presenting with apparent calcifications in the axillary lymph node on a screening mammogram.
The patient, a 35-year-old woman, was obtaining a baseline mammogram. She had extensive tattoos over her shoulders, arms, and back and had a mother who had been diagnosed with breast cancer when she was 55 years old.
After a bilateral mammogram, physicians detected a foci of calcification density around the right axillary lymph node. After fine-needle aspiration, pathologists determined that tattoo ink had been the true culprit behind the mammographic findings.
The researchers note that at least 30 different pigments are commercially available, each with varying levels of metallic ions. Tattoo artists will mix different inks to achieve subtle variations in shades and colors, making it difficult to determine which tattoos will lead to abnormal mammograms.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
